Liem Binh Luong, MD

AP-HP, Hôpital Cochin; Inserm CIC 1417, Paris, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France, France

Disclosure(s): Pfizer: Advisor/Consultant, Honoraria

Poster(s):

• 1954 - Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET